Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Return on Equity (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Return on Equity for 14 consecutive years, with 0.0% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 1.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.0% for FY2025, 1.0% up from the prior year.
  • Return on Equity hit 0.0% in Q4 2025 for Perspective Therapeutics, up from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q4 2025 to a low of 0.17% in Q4 2022.
  • Historically, Return on Equity has averaged 0.06% across 5 years, with a median of 0.05% in 2024.
  • Biggest five-year swings in Return on Equity: surged 58bps in 2021 and later decreased -12bps in 2022.
  • Year by year, Return on Equity stood at 0.05% in 2021, then plummeted by -249bps to 0.17% in 2022, then soared by 40bps to 0.1% in 2023, then surged by 97bps to 0.0% in 2024, then soared by 175bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for CATX at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.